2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¿¡½ºµð¾¾, ½Ò·Î ¸¸µç ±â´É¼ºÇ¥½Ã½Äǰ ¡®Çѳ¢¾îÅÍ¡¯ (2021-06-25)
¼¼°è Áöµµ¿¡ Çõ½ÅÀû À§Ä¡ Á¤º¸ Á¢¸ñ (2018-12-17)
¹ÌÅ͹ý »ç¿ë, Á¤ÂøµÇ¾î °£´Ù (2014-02-04)
ƼÇǸµÅ©, Æ÷ºê½º ¼±Á¤ ¡®°í°´½Å·Úµµ 1À§¡¯ (2021-08-29)
¹ÚÀº¼® ¼Ò¼Ó»ç, ¹Ý·Áµ¿¹° °ü·Ã °ø½ÄÀÔÀå (2021-01-27)
Çö´ëÀÚµ¿Â÷, 'Á¦7ȸ Çö´ë ŰÁî ¸ðÅͼî' °³ÃÖ (2023-05-05)
ÀüÀÚÁ¤ºÎ½ÉÀå Á¤ºÎÅëÇÕÀü»ê¼¾ÅÍ (2012-11-05)
LG»ýȰ°Ç°­, Avon ¹Ì±¹¡¤Ä³³ª´Ù¡¤Çª¿¡¸£Åä ¸®ÄÚ »ç¾÷ Àμö (2019-04-26)
Àӻ깰 °¡Ä¡¡¤ÀÚ¿ø Ȱ¿ëÇÑ Èú¸µ Á¦°ø (2021-08-01)
¼ÒÀ½ ¹Î°¨°èÃþ ÇÇÇØ ¹è»ó±âÁØ °­È­ (2018-12-26)
SK±×·ì, CES 2023¼­ ¡®³Ý Á¦·Î¡¯ ±â¼úÀÇ Ç⿬ ÆîÄ£´Ù (2023-01-04)
À̺ê Äܵ¼, Çΰŵ¼¢ç »óÇ¥±Ç µî·Ï (2021-04-02)
Çѱ¹ÀÚ»ê°ü¸®°ø»ç¡¤KOTRA¡¤Á¦ÁÖÅ×Å©³ëÆÄÅ© ä¿ë ¼Ò½Ä (2018-07-30)
¾Ë¹Ù¸óxÄô¾ß ijġ¸¶Àεå, ÄÝ¶óº¸ À̺¥Æ® (2019-10-01)
Çö´ëÂ÷, Á¤º¸º¸¾È ºÐ¾ß ½ÅÀÔ-°æ·Â ä¿ë (2021-07-04)
Çѱ¹¹Î¼ÓÃÌ ¡®¹°ÃѺδë, ´õÀ§¿ÍÀÇ ÀüÀ (2021-07-04)
ÇϹݱâ ä¿ë, ´ë±â¾÷ ¡®È¸º¹¡¯ vs Áß°ßÁß¼Ò ¡®Ä§Ã¼¡¯ (2020-08-03)
°ø¹«¿ø Á÷Á¾ ºÐ·ù 31³â¸¸¿¡ °³Æí (2012-11-23)
ÀÌÅ»¸®¾Æ ÆÐ¼Ç ºê·£µåµé, »ß¿¡·Î¼îÇÎ 1È£Á¡¿¡ ÀÔÁ¡ (2018-07-02)
°øÂ÷ÄÚ¸®¾Æ, 5¿ù ¹è´Þ ¾Û ÇÒÀÎ À̺¥Æ® (2022-05-07)
SKÅÚ·¹ÄÞ, ´ë±¸ Àü¿ª¿¡ IoT Àü¿ë¸Á (2016-05-30)
µÎ¿ø°ø´ë, Àü¹®´ë Áö¼ÓÁö¼ö °æ¿µ ºÎ¹® 1À§ (2020-11-04)
³î´ã, ¡®ÇÔ²²µ¹º½¡¯ ´ë±¹¹Î Ä·ÆäÀÎ (2020-11-04)
±Ý°¨¿øÀÇ Æ¯»ç°æ ¿î¿µ °£¼·Çؼ± ¾ÈµÈ´Ù (2019-05-05)
¼­¿ï½Ã, Á¶·Ê°³Á¤À¸·Î ȯ°æ¿µÇâÆò°¡ Á¦µµ ÇÕ¸®È­ (2019-01-04)
       [ÀÌÀü][1]....[2866][2867][2868][2869][2870][2871][2872][2873][2874]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..